share_log

Piper Sandler:重申Teva Pharmaceutical Indus(TEVA.US)评级,由增持调整至增持评级, 目标价由19.00美元调整至20.00美元。

Zhitong Finance ·  May 13 08:55

Piper Sandler:重申Teva Pharmaceutical Indus(TEVA.US)评级,由增持调整至增持评级, 目标价由19.00美元调整至20.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment